|
This is an archive page. The links are no longer being updated. Calendar Year 2000 Congressional Testimonies
December 5, 2000 - - Jonca Bull, Deputy Director, Office of Drug Evaluation, Center for Drug Evaluation and Research, (FDA)
October 5, 2000 - - Drue Barrett, Chief, Health Activity Working Group, National Center for Environmental Health (CDC)
October 5, 2000 - - David Satcher, Surgeon
General and Assistant Secretary for Health
October 3, 2000 - - Olivia Golden, Assistant Secretary, (ACF)
October 3, 2000 - - Jane Henney, Commissioner, (FDA)
September 28, 2000 - - Greg Koski, Director, Office of Human Research Protections
September 26, 2000 - - Joseph Levitt, Director (FDA)
September 25, 2000 - - Joseph Levitt, Director (FDA)
September 21, 2000 - - Kevin Yeskey, MD
September 21, 2000 - - Bernard S. Arons, M.D.
September 20, 2000 - - Stephen M. Ostroff, M.D.
September 20, 2000 - - Jane E. Henney, M.D.
September 20, 2000 - - Jeffrey P. Koplan, M.D., M.P.H.
September 20, 2000 - - Statement for the Record
September 19, 2000 - - William Raub, Ph.D
September 13, 2000 -- Statement for the Record
September 7, 2000 - - Gerald D. Fischbach, M.D. (NIH)
September 7, 2000 - - Robert A. Berenson, M.D. (HCFA)
September 6, 2000 - - Timothy Westmoreland (HCFA)
September 5, 2000 - - Steven Pelovitz (HCFA)
August 9, 2000 - - Allen M. Spiegel, M.D. (NIH)
July
27, 2000 -- Nancy-Ann DeParle (HCFA)
July
26, 2000 -- Ruth L. Kirschstein, M.D. (NIH)
Subject: Health Disparites, Bridging the Gap
July 26, 2000 -- John Callahan (HHS)
July 25, 2000 -- Robert
A. Berenson, M.D.
(HCFA) July
25, 2000 -- Penny Thompson (HCFA) Subject: Preventing Medicaid Fraud July 20, 2000 - - Francis S. Collins, M.D., Ph.D. (NIH)
July 18, 2000 -- William Egan,
Ph.D. (FDA) Subject: Mercury in Medicine July
18, 2000 -- Marie M. Bristol-Power, Ph.D. (NIH)
Subject: Mercury in Medicine
July 13, 2000 -- Don Lollar, Ed. D. (CDC)
July 13, 2000 -- Rachael Weinstein, R.N. (HCFA)
July 13, 2000 -- Kathryn C. Zoon, Ph.D. (FDA)
July
12, 2000 -- Kathryn C. Zoon, Ph.D. (FDA) July
12, 2000 -- Penny Thompson (HCFA)
July 11, 2000 -- Dr. Claude Earl Fox, M.D. , M.P.H.
(HRSA)
July 11, 2000 -- Gary Christoph, Ph.D.
(HCFA)
July 11, 2000 -- Robert Berenson, M.D.
(HCFA) June 29, 2000 -- David Satcher, M.D., Ph.D.
(OPHS) June 27, 2000 -- David W. Feigal, M.D.
(FDA)
June 27, 2000 -- Michael Hash (HCFA)
June 26, 2000 -- Jeffrey Kang, M.D. (HCFA)
June 22, 2000 -- Linda Rosenstock, M.D., M.P.H. (CDC)
June 15, 2000 -- Linda A. Suydam, D.P.A. (FDA)
June 15, 2000 -- Dixie E. Snider, M.D., M.P.H. (CDC)
June 14, 2000 -- Nancy-Ann DeParle (HCFA) Subject: Medicare
Prescription Drug Benefit
June 14, 2000 -- Kathy Buto, (HCFA)
June 14, 2000 -- Robert Berenson, M.D. (HCFA)
June 13, 2000 -- Nancy-Ann Deparle (HCFA)
June 8, 2000 -- Dennis E. Baker, Associate Commissioner (FDA) June 7, 2000 --
Jeffrey Kang, MD (HCFA)
June 7, 2000 -- Richard Pazdur, M.D. (FDA)
May 25, 2000 -- William K. Hubbard, Senior Associate (FDA) May 25, 2000 -- William F. Raub, Ph.D. (HHS)
May 18, 2000 -- John Strandberg, D.V.M., Ph.D.
(NCRR)
May 16, 2000 -- Steven E. Hyman, M.D. (NIMH)
May 16, 2000 -- Cindy Mann (HCFA)
May 16, 2000 -- Michael H. Trujillo, MD, M.P.H., M.S.
(IHS)
May
11, 2000 -- David Satcher, M.D., Ph.D. (OPHS) Subject: The Health Care Fairness Act of 1999
May 4, 2000 -- Nancy-Ann DeParle (HCFA) Subject: Medicare Governance
May 3, 2000 -- William F. Raub, Ph.D. (HHS)
May 2, 2000 -- Kenneth Olden, Ph.D. (NIH)
May 2, 2000 -- Duane Alexander, M.D. (NIH)
May 2, 2000 -- Richard J. Jackson, M.D., M.P.H. (CDC)
April 26, 2000 -- Allen M. Spiegel, M.D. (NIH)
April 13, 2000 -- Food and Drug Administration
April 13, 2000 -- Food and Drug Administration
April 13, 2000 -- Duane Alexander, M.D. (NIH)
April 10, 2000 -- Dorothy Burk Collins (HCFA)
April 6, 2000 -- Coleen Boyle, Ph.D. (CDC)
April 6, 2000 -- Deborah G. Hirtz, M.D. (NIH)
April 6, 2000 -- Penny Thompson (HCFA)
April 5, 2000 -- Tim Westmoreland (HCFA)
March 29, 2000 -- Michael Hash (HCFA)
March 23, 2000 -- Claude Earl Fox, M.D., M.P.H. (HRSA)
March 23, 2000 -- Michael Hash (HCFA)
March 21, 2000 -- Jane E. Henney, M.D. (FDA)
March 16, 2000 -- Thomas Croft (HRSA)
March 15, 2000 -- Ronald Coene (FDA) March 15, 2000 -- Michael Hash (HCFA) Subject: Fiscal 1999 Chief Financial Officers' Audit
March 14, 2000 -- Alan I. Leshner, Ph.D. (NIH)
March 14, 2000 -- Nelba Chavez, Ph.D. (SAMHSA)
March 9, 2000 -- Nancy-Ann DeParle (HCFA)
March 8, 2000 -- Robert F. Knouss, M.D. (OPHS)
March 8, 2000 -- Michael H. Trujillo, M.D., M.P.H.,
M.S. (IHS)
March 8, 2000 -- Claude Earl Fox, M.D., M.P.H. (HRSA)
March 8, 2000 -- Stephen M. Ostroff, M.D. (CDC)
March 6, 2000 -- Michael Mcmullan (HCFA)
February 29, 2000 -- The Honorable Donna E. Shalala (HHS)
February 17, 2000 -- Margaret A. Hamburg, M.D. (HHS)
February 17, 2000 -- Olivia A. Golden (ACF)
February 17, 2000 -- Camille Barry, Ph.D., R.N. (SAMHSA)
February 16, 2000 -- Henry Falk, M.D. (ATSDR)
February 16, 2000 -- Bonnie Washington (HCFA)
February 14, 2000 -- Helene Gayle, M.D., M.P.H. (CDC)
February 10, 2000 -- David W. Feigal, M.D. (FDA)
February 8, 2000 -- The Honorable Donna E. Shalala (HHS)
February 8, 2000 -- Steven E. Hyman, M.D. (NIH)
February 8, 2000 -- David Satcher, M.D., Ph.D. (OPHS)
February 2, 2000 -- Amy Patterson, M.D. (NIH)
February 2, 2000 -- Jay P. Siegel, M.D. (FDA)
February 2, 2000 -- Drue H. Barrett, Ph.D. (CDC)
February 1, 2000 -- Janet Woodcock (FDA)
HHS Home | ASL Home Disclaimers | Privacy Notice | FOIA | Accessibility | Contact Us Last Revised: January 25, 2007 |